A novel fully human antitumour immunoRNase targeting ErbB2-positive tumours

BACKGROUND: ErbB2 is an attractive target for immunotherapy, as it is a tyrosine kinase receptor overexpressed on tumour cells of different origin, with a key role in the development of malignancy. Trastuzumab, the only humanised anti-ErbB2 antibody currently used in breast cancer with success, can...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Borriello, M, Laccetti, P, Terrazzano, G, D'Alessio, G, De Lorenzo, C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2011
Gaiak:
Translational Therapeutics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3111160/
https://ncbi.nlm.nih.gov/pubmed/21559015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.146
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak